标准化抗心衰治疗在心衰伴俯身呼吸困难患者中的应用价值分析

Analysis on the Application Value of Standardized Treatment of Heart Failure in Patients with Heart Failure Combined with Dyspnea in Prone Positioning

目的:探讨标准化抗心衰治疗在心衰伴俯身呼吸困难患者中的应用价值。方法:以70例心衰伴俯身呼吸困难患者为对象,分为对照组与观察组,对比两组治疗疗效。结果:观察组总有效率为91.43%,高于对照组68.57%,(P<0.05)。两组治疗后6分钟步行距离(6MWD)水平升高,N末端B型利钠钛前体(NT-proBNP)、基质金属蛋白酶-9(MMP-9)水平降低,观察组变化幅度高于对照组(P<0.05)。观察组心血管事件发生率为11.43%,低于对照组34.29%,(P<0.05)。结论:标准化抗心衰治疗心衰合并俯身呼吸困难患者的效果较好,可改善患者心功能及预后。

To explore the application value of standardized heart failure therapy in patients with heart failure combined with dyspnea in prone positioning.Methods:Seventy patients with heart failure and dyspnea in prone positioning were divided into a control group and an observation group.The therapeutic effects of the two groups were compared.Results:The total effective rate of the observation group was 91.43%,which was higher than that of the control group(68.57%),P<0.05.After treatment,the level of 6-min walking distance increased,the level of N-terminal-pro hormone BNP(NT proBNP)and matrix metalloproteinase-9(MMP-9)decreased in the two groups,and the change in the observation group was bigger than that in the control group(P<0.05).The incidence of cardiovascular events in the observation group was 11.43%,which was lower than that in the control group(34.29%,P<0.05).Conclusion:The standardized treatment of patients with heart failure combined with dyspnea in prone positioning is better,which can improve the heart function and prognosis of patients.